Company Filing History:
Years Active: 2025
Title: Ilse Vanhorebeek: Innovator in Critical Care Treatment
Introduction
Ilse Vanhorebeek is a notable inventor based in Lubbeek, Belgium. She has made significant contributions to the field of critical care treatment through her innovative research and inventions. Her work focuses on addressing critical illness myopathy and polyneuropathy, which are serious complications arising from critical illnesses.
Latest Patents
Ilse Vanhorebeek holds 1 patent for her invention titled "3-hydroxybutyrate alone or in combination for use in the treatment of critical care treatment." This invention relates to methods and compositions aimed at treating or preventing critical illness myopathy and polyneuropathy, particularly in patients suffering from conditions such as sepsis and septic shock. The use of a combination of parenteral or enteral feeding with 3-hydroxybutyrate is a key aspect of her patent.
Career Highlights
Vanhorebeek's career is marked by her dedication to advancing medical treatments for critically ill patients. Her research has been instrumental in developing effective strategies to combat the debilitating effects of critical illness on muscle and nerve function. She is affiliated with Katholieke Universiteit Leuven, where she continues her impactful work.
Collaborations
Ilse collaborates with esteemed colleagues, including Chloe Christian Goossens and Lies Langouche, who contribute to her research efforts and enhance the scope of her projects.
Conclusion
Ilse Vanhorebeek's innovative work in critical care treatment exemplifies her commitment to improving patient outcomes in critical illness. Her contributions through her patent and collaborations highlight the importance of research in advancing medical science.